Class II · Moderate risk
Cistus Canadensis 5X Coldness* 20% Alcohol drops
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
FDA drug recalls in 2021
Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,152 recalls, newest first.
Class II · Moderate risk
Althaea 30X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Althaea 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Althaea 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Althaea Officinalis 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Kali Sulphuricum 3X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
La Core LCL-2-0191 Blend
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Viola Odorata 4X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Verbena Officinalis 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Quebracho 4C
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Humulus 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Cistus Canadensis 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Cinnamomum 6X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Althaea Officinalis 4X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Cedar Fever Drops
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Haloderm Homeopathic Blend
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Yeast Guard Blend
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Occular Allergy Blend 87% Alcohol
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
ZTE-105 Formula Gentle Detoxing. Contents 1000 mL
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class II · Moderate risk
Aconitum nap Fear* 87% Alcohol HPUS: 5X
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Class III · Low risk
Donepezil HCL Tablets
Subpotent
Class II · Moderate risk
Oxycodone Hydrochloride Tablets
Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle
Class II · Moderate risk
Trulicity (dulaglutide)
Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.
Class I · High risk
X Rated Honey for Men
Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.
Class II · Moderate risk
Spironolactone Ophthalmic Solution 0.005 mg/mL
Lack of Assurance of Sterility